Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

Conditions:   Amyotrophic Lateral Sclerosis;   ALS;   Lou Gehrig Disease;   Lou Gehrig's Disease;   Lou-Gehrigs Disease;   Motor Neuron Disease, Amyotrophic Lateral Sclerosis Intervention:   Drug: BHV-0223 Sponsors:   Biohaven Pharmaceutical Holding Company Ltd.;   Cognitive Research Corporation (CRC) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials